OPBS 2026 Day 3 and Final Course Evaluation

Advanced Oncoplastic Breast Surgical Skills Course 2026

Wednesday, 30 September 2026
Implant-Based Reconstruction and Lipomodelling

This combined evaluation includes Day 3 lecture-level feedback and the final course evaluation. It should take approximately 10–12 minutes. Please rate only sessions attended and select Not attended / Not applicable for parallel or missed activities. Individual Day 1 and Day 2 lectures are not repeated because they are assessed in the separate daily forms.

Email Address for Certificate Communication *

Name as It Should Appear on Your Certificate *

Country of Practice *

Current Professional Grade / Role *

Course Pathway *

Days Attended *Day 1 – Monday, 28 SeptemberDay 2 – Tuesday, 29 SeptemberDay 3 – Wednesday, 30 September

Course Components Attended *Morning scientific teachingMDT simulation and case discussionSkin-marking demonstrationsLive surgical demonstration / transmissionTheatre participation as an approved operative candidateParallel complications sessions

Lecture and Session Assessment

Please assess each lecture or educational session directly.

Implant-Based Reconstruction: Patient Selection, Measurements, Safety and Outcomes *1 – Poor2 – Fair3 – Satisfactory4 – Very Good5 – ExcellentNot attended / Not applicable

Daily Educational Experience

A short overall assessment of today.

What was your most important learning point today? *

Which session was most useful, and why? *

What is the single most important improvement we should make? *

Did you observe any patient-safety, professional-conduct or governance concern? *NoYes – I wish to provide detailsI prefer to discuss this confidentially with the Course Director

If applicable, provide a brief note and preferred contact details (optional).

Overall Course Quality

Evaluate the course as a complete educational experience.

Learning Outcomes and Confidence

Avoiding repetition with daily lecture ratings, these questions assess the overall educational impact.

Following the course, I am better able to: Select and plan appropriate therapeutic mammoplasty techniques and pedicles *Strongly disagreeDisagreeNeutralAgreeStrongly agreeNot applicable

Following the course, I am better able to: Plan chest-wall perforator flap reconstruction, including LICAP, LTAP, MICAP and AICAP options *Strongly disagreeDisagreeNeutralAgreeStrongly agreeNot applicable

Following the course, I am better able to: Apply MDT, consent, governance and patient-safety principles to complex oncoplastic practice *Strongly disagreeDisagreeNeutralAgreeStrongly agreeNot applicable

Which area of confidence improved the most, and why? *

Observer Pathway Evaluation

Displayed only to Observer Delegates.

What was the most valuable aspect of the Observer Pathway? *

How should the Observer Pathway be improved? *

Operative Pathway Evaluation

Displayed only to Operative Candidates.

Which supervised operative component was most educational? *

How should the Operative Pathway be improved? *

Governance, Safety and Impact on Practice

Please evaluate the safety framework and likely impact on your clinical practice.

Did you observe or experience any patient-safety, professional-conduct or governance concern? *NoYes – I wish to provide detailsI prefer to discuss this confidentially with the Course Director

If applicable, provide details or preferred contact arrangements.

Will this course change or refine your clinical practice? *YesPossiblyNoNot applicable

What is the most important change you intend to make? *

Do you require further supervised training before applying any demonstrated technique? *YesNoNot sureNot applicable

Overall Assessment and Future Development

A small number of direct questions to guide the next course.

Did the course meet your expectations? *Yes – fullyYes – partlyNo

What was the most important thing you learned? *

Please list up to three aspects that worked particularly well. *

Please list up to three priority improvements. *

Which topics should future ESBS courses address? *

Additional comments (optional)

Data Use and Consent

The core evaluation use is distinguished from optional promotional and research uses.

Quality-Improvement and CPD Use *I understand that my feedback will be analysed in aggregated or anonymised form for course evaluation, quality improvement, CPD reporting and review by relevant educational or endorsing bodies.

May an anonymised quotation from your feedback be used in future ESBS course information or promotional material? *YesNo

May anonymised feedback be included in educational audit, research or conference presentation? *YesNo

Day 3 and Final Course Evaluation

Final course evaluation

Day 3 session rating scale